aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
MedCrypt secures medical devices with real-time threat detection and community threat sharing.
MedCrypt, founded with the mission to secure medical devices, provides cybersecurity solutions tailored for medical device manufacturers. Their core vision is to enable developers to focus on healthcare innovation while ensuring compliance with security regulations. MedCrypt offers a security toolkit that integrates real-time threat detection and community threat sharing, alongside their product Helm, which manages Software Bill of Materials (SBOM) and vulnerabilities. This helps manufacturers build secure devices faster and meet FDA cybersecurity requirements.
Notable figures in MedCrypt include its founders and key investors who have supported its growth. The company has achieved significant milestones, such as developing machine learning-based transaction monitoring algorithms that detect and thwart attacks in real time. MedCrypt's impact is evident in its ability to centralize transaction data for enhanced threat sharing, thereby improving the overall security landscape of medical devices and contributing to safer healthcare technology.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Software, Cybersecurity
Technology
AI, Machine Learning
Tags
Healthtech, SaaS
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was MedCrypt founded?
MedCrypt was founded in 2016.
Where is MedCrypt’s headquarters located?
MedCrypt’s headquarters is located in Encinitas, CA, US.
How many employees does MedCrypt have?
MedCrypt has 59 employees as of Feb 5, 2024.
How much has MedCrypt raised to-date?
As of July 05, 2023, MedCrypt has raised a total of $34.4M (USD) since Jan 24, 2023.
Add Comparison
Total Raised to Date
$34.4M
USD
Last Update Jan 24, 2023
Total Employees Over Time
59
As of Feb 2024
MedCrypt Address
1302 N Coast Highway
101 suite 102
Encinitas,
California
92024
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts